semaglutide side effects hair loss female GLP-1 therapies and loss: A systematic review of current evidence and implications for counseling Does Semaglutide or Tirzepatide Cause
Description
2025 2

37 Significant muscle loss can lead to weakness, reduced mobility, poor balance, and an increased risk of falls and debilitating fractures

Orforglipron is the worlds second oral GLP-1 pill for weight management, approved by the FDA in April 2026
:max_bytes(150000):strip_icc()/Health-GettyImages-1413029048-1570d2105e4840479118ceddf6c46e19.jpg)
These lawsuits allege that Wegovys manufacturer, Novo Nordisk, failed to warn about the risks

Clinical studies of certain FDA-approved GLP-1 medications show differences in average weight loss compared to phentermine

UK guidance typically recommends a more gradual weight loss of 0.5-1 kg per week where feasible
